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Finding a sustainable alternative for today’s petrochemical industry is a major challenge facing chemical 
engineers and society at large. To be sustainable, routes for converting carbon dioxide and light into organic 
compounds for use as both fuels and chemical building blocks must be identified, understood, and engineered. 
Furthermore, these routes must be economically competitive with current and future fossil fuel sources and not 
irreversibly deplete other natural resources (e.g. food, water). Terrestrial lignocellulosic biomass (e.g. 
agricultural wastes, energy crops, and forestry reserves) has been the subject of extensive R&D for use as a 
renewable carbon feedstock for producing biofuels and displacing petrochemicals. Despite this significant effort, 
many challenges to commercialization remain. These problems include cultivation costs, transportation, 
processing, and a mismatch between available supply and current petrochemical demand. A possible 
alternative and/or supplement is the use of aquatic phototrophs such as eukaryotic algae or prokaryotic 
cyanobacteria to directly produce chemicals and biofuels, skipping the biomass middle-man. In this talk, I will 
describe my group's efforts to develop Synechococcus sp. strain PCC7002 as a model phototroph for chemical 
production from sunlight and carbon dioxide. PCC7002 is attractive because it is one of the fastest growing 
photoautotrophs, halotolerant, naturally transformable, and well represented in the literature. Our initial attempts 
to apply metabolic engineering in this strain failed miserably due to a lack of reliable genetic and synthetic 
biology tools (e.g. segregation drivers, controllable promoters, terminators). To address this problem, we 
assembled a toolbox for working with PCC7002 and have applied the tools to engineer strains capable of 
producing lysine, lactate, and glycogen. In this talk, I will describe our toolbox development (promoters, 
CRISPRi, CRISPR genome editing), our ongoing metabolic engineering studies, and the remaining obstacles to 
deploying cyanobacterial biorefineries.  
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